X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
female (9) 9
male (9) 9
cancer (8) 8
index medicus (8) 8
middle aged (8) 8
adult (7) 7
chemotherapy (7) 7
lymphomas (7) 7
adolescent (6) 6
aged (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
non-hodgkins-lymphoma (5) 5
prednisone - administration & dosage (5) 5
young adult (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
doxorubicin - administration & dosage (4) 4
hematology, oncology and palliative medicine (4) 4
hodgkin disease - drug therapy (4) 4
oncology (4) 4
rituximab (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
analysis (3) 3
bleomycin - administration & dosage (3) 3
care and treatment (3) 3
clinical trials (3) 3
cyclophosphamide (3) 3
cyclophosphamide - administration & dosage (3) 3
disease (3) 3
disease-free survival (3) 3
follow-up studies (3) 3
hematology (3) 3
hodgkin's disease (3) 3
life sciences (3) 3
lymphoma (3) 3
lymphoma, large b-cell, diffuse - drug therapy (3) 3
medical research (3) 3
medicine, experimental (3) 3
medicine, general & internal (3) 3
prednisone - adverse effects (3) 3
response criteria (3) 3
survival (3) 3
tumors (3) 3
vinblastine - administration & dosage (3) 3
vincristine (3) 3
vincristine - administration & dosage (3) 3
age (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antineoplastic agents - therapeutic use (2) 2
b cells (2) 2
bleomycin (2) 2
bleomycin - adverse effects (2) 2
confidence intervals (2) 2
cyclophosphamide - adverse effects (2) 2
doxorubicin (2) 2
doxorubicin - adverse effects (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
elderly-patients (2) 2
hodgkin disease - pathology (2) 2
hodgkin disease - radiotherapy (2) 2
infection (2) 2
internal medicine (2) 2
lymphoma, large b-cell, diffuse - mortality (2) 2
patients (2) 2
pet imaging (2) 2
population studies (2) 2
prednisone (2) 2
radiation (2) 2
radiology, nuclear medicine & medical imaging (2) 2
radiotherapy (2) 2
remission induction (2) 2
risk factors (2) 2
side effects (2) 2
therapy (2) 2
toxicity (2) 2
tumor burden (2) 2
usage (2) 2
3600 (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[ sdv.imm ] life sciences [q-bio]/immunology (1) 1
[sdv.can] life sciences [q-bio]/cancer (1) 1
[sdv.imm]life sciences [q-bio]/immunology (1) 1
actors (1) 1
actresses (1) 1
adults (1) 1
age factors (1) 1
aged patients (1) 1
aggressive lymphoma (1) 1
aggressive lymphomas (1) 1
anthracyclines (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibody (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESPONSE CRITERIA | AGGRESSIVE LYMPHOMAS | POOR-PROGNOSIS | NON-HODGKINS-LYMPHOMA | REGIMEN | YOUNG-PATIENTS | ELDERLY-PATIENTS | DES-LYMPHOMES | TRANSPLANTATION | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 12, pp. 1160 - 1170
Summary Background Little is known about the longitudinal course of health-related quality of life (HRQoL) in patients with Hodgkin's lymphoma during their... 
Hematology, Oncology and Palliative Medicine | INSTRUMENT | LONG-TERM SURVIVORS | GENERAL-POPULATION | ONCOLOGY | FATIGUE | QLQ-C30 | DISEASE SURVIVORS | CANCER | Hodgkin Disease - psychology | Follow-Up Studies | Humans | Middle Aged | Adolescent | Hodgkin Disease - drug therapy | Quality of Life | Adult | Female | Male | Aged
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 5, pp. 1047 - 1052
Purpose This study examines the role of18 F-labeled fluorodeoxyglucose positron emission tomography (FDG-PET) in the implementation of involved-node radiation... 
Radiology | Hematology, Oncology and Palliative Medicine | IMPACT | RESPONSE CRITERIA | VOLUMES | ONCOLOGY | FIELD | GUIDELINES | DISEASE | SCANS | SEGMENTATION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Hodgkin Disease - diagnostic imaging | Fluorodeoxyglucose F18 - pharmacokinetics | Confidence Intervals | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - pathology | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Vinblastine - administration & dosage | Young Adult | Hodgkin Disease - radiotherapy | Multimodal Imaging - methods | Hodgkin Disease - drug therapy | Adult | Female | Doxorubicin - administration & dosage | Lymphatic Irradiation - methods | Dacarbazine - administration & dosage | Radiopharmaceuticals - pharmacokinetics | Bleomycin - administration & dosage | Positron-Emission Tomography - methods | Tumor Burden | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged | Diaphragm | Lymph Nodes - diagnostic imaging | Antimitotic agents | Sects | Care and treatment | PET imaging | Radiation | Lymphomas | Radiotherapy | Antineoplastic agents | Cancer | CT imaging | Medical research | Chemotherapy | Analysis | Medicine, Experimental | PATIENTS | QUALITY ASSURANCE | LYMPH NODES | FLUORODEOXYGLUCOSE | HODGKINS DISEASE | MEDICAL PERSONNEL | CHEMOTHERAPY | CAT SCANNING | PLANNING | POSITRON COMPUTED TOMOGRAPHY | RADIOLOGY AND NUCLEAR MEDICINE | FLUORINE 18
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2017, Volume 4, Issue 1, pp. e46 - e55
Journal Article
Cancer, ISSN 0008-543X, 04/2009, Volume 115, Issue 8, pp. 1680 - 1691
BACKGROUND: The objective of this study was to analyze cause‐specific excess mortality in adult patients with Hodgkin lymphoma (HL) with respect to treatment... 
relative survival | causes of death | Hodgkin lymphoma | long‐term survival | Long-term survival | Causes of death | Relative survival | Prognosis | Toxicity | Mortality | Radiation | Population studies | Regression analysis | Radiotherapy | Survival | Infection | Chemotherapy | Models | Cardiovascular diseases | Age | Hodgkin's disease | Cancer | Life Sciences
Journal Article
Medicine (United States), ISSN 0025-7974, 11/2014, Volume 93, Issue 21, p. e121
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 04/2018, Volume 100, Issue 5, pp. 1133 - 1145
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 09/1997, Volume 80, Issue 6, pp. 1124 - 1133
BACKGROUND To determine whether a high risk group could be identified within a group of patients with advanced stage Hodgkin's disease (HD), the authors... 
high dose chemotherapy | Lymph Node | prognostic factors | salvage therapy | Hodgkin's disease
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.